ArticleFrontiers in toxicology2026
Urinary heavy metal and trace element mixtures in chronic kidney disease: associations and implications for potential reverse causality.
Article in Frontiers in toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Chronic kidney disease (CKD) is a growing public health challenge, yet impaired kidney function may substantially alter urinary biomarker profiles, complicating their interpretation. We aimed to investigate the associations between urinary element concentrations and prevalent CKD, and to explore whether impaired kidney function and altered urinary excretion may contribute to reverse causality in the interpretation of urinary biomarkers. Methods: We conducted a cross-sectional analysis of urinary element mixtures and prevalent CKD among 6,192 adults (51.7% female; mean age 52.4 ± 10.7 years). Associations between urinary element concentrations and prevalent CKD were evaluated using logistic regression, restricted cubic spline models, and three mixture modeling approaches, including Bayesian kernel machine regression, weighted quantile sum regression, and quantile g-computation. Results: Participants with CKD exhibited lower urinary concentrations of selenium, molybdenum, cadmium, mercury, lead, and thallium, whereas urinary zinc concentrations were higher. Non-linear associations were observed for several elements. Across multiple mixture models, higher combined urinary element concentrations were consistently associated with lower odds of prevalent CKD. Cadmium, mercury, selenium, and thallium contributed most strongly to these inverse associations, whereas zinc showed a positive contribution. Discussion: These findings are unlikely to reflect protective effects and may instead reflect impaired urinary excretion resulting from kidney dysfunction. Our findings suggest that urinary elements in CKD reflect not only exposure but also disease-related alterations in renal excretory function. These findings highlight the potential for reverse causality when interpreting urinary elements as biomarkers or predictors of kidney outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.